As readers of this blog surely know, NIA publishes Funding Opportunity Announcements (FOAs) in the NIH Guide to—you guessed it—announce new opportunities to apply for funding. We use FOAs to inform potential applicants of new initiatives ranging from traditional R01 research grants to large P50 center grants and national surveys. But have you stopped to think about where an FOA originates? Read on for a behind-the-scenes look at FOA development.
Small smiles of satisfaction spread around the staff in my office last week. The NIH Guide published the last of our long-running saga of funding opportunity announcements (FOAs) on Alzheimer’s disease and Alzheimer’s-related dementias (ADRD). These were the concepts that the National Advisory Council on Aging approved last September (Thank you again, everyone!).
The mighty push for research on Alzheimer’s disease and related dementias continues at NIA. While an earlier blog highlighted the research initiatives we have published, this chapter covers the more recent publication of two training initiatives and four small business-related initiatives.
As most of you probably know, there has been a big influx of funds for Alzheimer’s disease research, with perhaps more to come. We recently issued several new Funding Opportunity Announcements (FOAs) focused on Alzheimer’s. A burning question in the minds of many scientists is: Can a basic biologist not currently working on Alzheimer’s really expect to receive funds targeted towards Alzheimer’s research?
I visited Cleveland over Thanksgiving. In a moment of peace from family conversations, I picked up the local paper. The first story I encountered was a long report on the Health and Retirement Study findings, funded by NIA, showing a substantial decline in U.S. dementia rates in the last 20 years. Then, I encountered a story reporting Eli Lilly’s negative clinical trial results on solanezumab. My immediate conclusion was that, no matter where I go, my job follows me!
As many of you know, if you’ve been reading this blog, both the Senate and House appropriations committees separately have passed bills calling for large increases in funds to support research on Alzheimer’s disease and related dementias. In fact, we’ve used that advance information to prepare to receive these funds, should they come our way in final legislation. That’s why we’re in the process of publishing many funding opportunity announcements that will take advantage of these funds, and other funds we will have, once we know our final budget.
Are you ready to let the good times roll in New Orleans at the annual meeting of the Gerontological Society of America (GSA)? We’re looking forward to seeing old friends and making new ones in the Big Easy. We also hope that you’ll take the opportunity to connect with NIA staff at the meeting, during scientific sessions, and in the Exhibit Hall.
The NIA recently created an online version of our Health Disparities Research Framework to showcase priorities and investments in this important aging research area. We hope that this site will serve as a resource for scientists interested in investigating health disparities related to aging. Please visit the page and take a look at the Framework’s interactive format.
Our National Advisory Council on Aging meeting last month proved to be very exciting. We have received increased public interest, together with additional funding in recent years, to accelerate progress against Alzheimer’s disease and related dementias. This has blossomed into numerous concepts for new initiatives that came before the Council to review. Their enormous accomplishment at this meeting was to approve 26 concept proposals for funding opportunities.
On June 7, NIA Director Dr. Richard Hodes announced that Dr. John Haaga had been appointed director of the Division of Behavioral and Social Research. Dr. Haaga was the acting director for the previous 15 months and the deputy director since 2004. "Inside NIA" sat down with Dr. Haaga to talk about his research plans for the division.